Annual Cash & Cash Equivalents
$13.72 M
-$3.28 M-19.29%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual cash & cash equivalents is currently $13.72 million, with the most recent change of -$3.28 million (-19.29%) on 31 December 2023. During the last 3 years, it has fallen by -$71.71 million (-83.94%). CRBP annual cash & cash equivalents is now -83.94% below its all-time high of $85.43 million, reached on 31 December 2020.CRBP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$19.42 M
-$4.26 M-18.00%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly cash and cash equivalents is currently $19.42 million, with the most recent change of -$4.26 million (-18.00%) on 30 September 2024. Over the past year, it has increased by +$8.17 million (+72.67%). CRBP quarterly cash and cash equivalents is now -78.40% below its all-time high of $89.92 million, reached on 31 March 2019.CRBP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | +72.7% |
| 3 y3 years | -83.9% | -47.7% |
| 5 y5 years | -67.1% | -64.6% |
CRBP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.9% | at low | -65.9% | +165.2% |
| 5 y | 5 years | -83.9% | at low | -77.3% | +165.2% |
| alltime | all time | -83.9% | +4429.3% | -78.4% | +6310.2% |
Corbus Pharmaceuticals Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.42 M(-18.0%) |
| June 2024 | - | $23.69 M(+67.9%) |
| Mar 2024 | - | $14.10 M(+2.8%) |
| Dec 2023 | $13.72 M(-19.3%) | $13.72 M(+22.0%) |
| Sept 2023 | - | $11.25 M(+34.7%) |
| June 2023 | - | $8.35 M(+14.0%) |
| Mar 2023 | - | $7.32 M(-56.9%) |
| Dec 2022 | $17.00 M(-32.0%) | $17.00 M(+36.6%) |
| Sept 2022 | - | $12.44 M(-51.7%) |
| June 2022 | - | $25.77 M(-54.8%) |
| Mar 2022 | - | $57.03 M(+128.0%) |
| Dec 2021 | $25.01 M(-70.7%) | $25.01 M(-32.6%) |
| Sept 2021 | - | $37.12 M(+2.9%) |
| June 2021 | - | $36.08 M(-45.8%) |
| Mar 2021 | - | $66.61 M(-22.0%) |
| Dec 2020 | $85.43 M(+169.1%) | $85.43 M(+4.4%) |
| Sept 2020 | - | $81.87 M(+29.0%) |
| June 2020 | - | $63.47 M(+36.1%) |
| Mar 2020 | - | $46.62 M(+46.8%) |
| Dec 2019 | $31.75 M | $31.75 M(-42.1%) |
| Sept 2019 | - | $54.85 M(-25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $73.15 M(-18.6%) |
| Mar 2019 | - | $89.92 M(+115.4%) |
| Dec 2018 | $41.75 M(-33.2%) | $41.75 M(-25.0%) |
| Sept 2018 | - | $55.66 M(-13.9%) |
| June 2018 | - | $64.68 M(-8.8%) |
| Mar 2018 | - | $70.96 M(+13.5%) |
| Dec 2017 | $62.54 M(+317.1%) | $62.54 M(+70.9%) |
| Sept 2017 | - | $36.60 M(-15.0%) |
| June 2017 | - | $43.03 M(-12.0%) |
| Mar 2017 | - | $48.93 M(+226.3%) |
| Dec 2016 | $14.99 M(+21.5%) | $14.99 M(-20.7%) |
| Sept 2016 | - | $18.91 M(-14.1%) |
| June 2016 | - | $22.02 M(+127.3%) |
| Mar 2016 | - | $9.69 M(-21.5%) |
| Dec 2015 | $12.34 M(+97.0%) | $12.34 M(-6.3%) |
| Sept 2015 | - | $13.17 M(+42.5%) |
| June 2015 | - | $9.24 M(+85.9%) |
| Mar 2015 | - | $4.97 M(-20.6%) |
| Dec 2014 | $6.26 M(+1966.8%) | $6.26 M(-16.9%) |
| Sept 2014 | - | $7.54 M(+2387.3%) |
| Dec 2013 | $303.00 K | $303.00 K |
FAQ
- What is Corbus Pharmaceuticals Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual cash & cash equivalents year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly cash and cash equivalents year-on-year change?
What is Corbus Pharmaceuticals Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of CRBP is $13.72 M
What is the all time high annual cash & cash equivalents for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual cash & cash equivalents is $85.43 M
What is Corbus Pharmaceuticals Holdings annual cash & cash equivalents year-on-year change?
Over the past year, CRBP annual cash & cash equivalents has changed by -$3.28 M (-19.29%)
What is Corbus Pharmaceuticals Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRBP is $19.42 M
What is the all time high quarterly cash and cash equivalents for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly cash and cash equivalents is $89.92 M
What is Corbus Pharmaceuticals Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, CRBP quarterly cash and cash equivalents has changed by +$8.17 M (+72.67%)